Dear Colleague,
You are invited to join Dr. Daniel Weiner for the 16th Advanced Level Workshop
on Pharmacokinetic - Pharmacodynamic Data Analysis.. Learn to apply advanced
approaches for conducting PK/PD analysis. This course has updated content,
hands-on problem solving that will include an introduction to population PK/PD
modeling.
Topics include:
Dose-response-time analysis, advanced principles of turnover modeling including
modeling tolerance and rebound, approaches to TMDD modeling, approaches to
optimizing sampling collection times, modeling PD effects for combination drug
treatments, pattern recognition, and translational aspects of PK/PD modeling.
Course includes:
* Complimentary copy of Pharmacokinetic & Pharmacodynamic Data Analysis
[with CDROM]
by Daniel Weiner.
* Lectures, group exercises with discussion, and hands-on PK/PD data analysis
including
population PK/PD modeling using Phoenix WinNonlin and NLME.
* Discussions and exercises will enable participants to master state-of-the-art
approaches to real-life problems.
Who should attend?
Scientists with at least five years of experience in PK/PD modeling
Don't miss this opportunity to increase your confidence in understanding basic
and advanced approaches to PK/PD modeling and to apply these approaches using
population methods.
Sign up today!
20% early registration discount (Expires December 15, 2014)
30% off of groups
50% off for students
Register Now https://www.certara.com/training/classes/72
Special rates available at the Courtyard Marriott,
http://www.marriott.com/hotels/travel/sanot-courtyard-san-diego-old-town/ if
reserved by January 15 2015.
Please ask for the Certara Meeting rate.
Daniel Weiner Ph.D.
Dr. Weiner has extensive drug development experience and has served as an
expert consultant to the U.S. Food and Drug Administration (FDA) on
pharmacokinetic modeling and bioequivalence assessment. Prior to his previous
tenure with Pharsight as a Senior Vice
President, Dr. Weiner held several management positions including Head,
Biostatistics, Merrell Dow Pharmaceuticals; Vice President, Statistical
Consultants, Inc.; Vice President, Syntex Development Research; Senior Vice
President and Principal Scientist, Quintiles,
and most recently, Senior Vice President and Global Head of Clinical
Development at IVAX Research.
Johan Gabrielsson
Johan Gabrielsson has been Senior Principal Scientist at AstraZeneca R&D
Mölndal. His responsibilities included kinetic/dynamic related project tasks in
the CV & GI & CNS & Cancer & Biologics areas. He is a co-author of the textbook
'Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications'
4th ed. (2006). He is professor of Integrative Pharmacology at the Swedish
Agricultural University in Uppsala, Sweden. He is also academically affiliated
with Dept. of Pharmaceutics, Univ. Tennessee and University of Manchester. He
has published extensively in the field of pharmacokinetic-pharmacodynamic
modelling and reasoning, and has run numerous courses internally and externally
in the area of biological data analysis since 1985 in Europe, the US and Asia
(>4000 participants) at both the undergraduate and graduate level. His research
focuses on modelling different aspects of endogenous turnover, such as
functional tolerance and rebound phenomena, physiological limits and
target-mediated drug disposition in collaboration with Professor LA Peletier,
Leiden University. He has been external examiner on several PhD Theses abroad.
Alicia Holmes
Sales Support Specialist
Certara(tm)
Implementing Translational Science
210 N. Tucker Blvd., Suite 350, St. Louis, MO 63101
Tel 314-951-3012 Fax 314-951-3099
Certara: The name behind the names you know
Tripos - Simcyp - Pharsight
http://www.certara.com/